跳至主要内容
临床试验/ACTRN12618001320246
ACTRN12618001320246已完成未知

OPtimisation of Perioperative Cardiovascular Management to Improve Surgical outcomE II trial (Optimise II) - biomarker sub-study for Australian sites

St Vincent's Hospital Melbourne0 个研究点目标入组 103 人开始时间: 2018年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • Patients who have consented and recruited to the OptimiseII trial which includes
  • patients aged 65 years and over undergoing major elective surgery involving the gastrointestinal tract that is expected to take longer than 90 minutes.

排除标准

  • Inability or refusal to provide patient consent
  • clinician refusal (including intention to monitor cardiac output from the start of surgery regardless of study group allocation)
  • American Society of Anesthesiologists (ASA) score of I
  • patients expected to die within 30 days
  • acute myocardial ischaemia within 30 days prior to randomisation
  • acute pulmonary oedema within 30 days prior to randomisation
  • contra-indication to low-dose inotropic medication
  • pregnancy at time of enrolment
  • current participation in another clinical trial of a treatment with a similar biological mechanism or primary outcome measure

研究者

发起方
St Vincent's Hospital Melbourne

相似试验